The identification and analysis of mexiletine and its metabolic products in man
- 1 September 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 29 (1) , 281-285
- https://doi.org/10.1111/j.2042-7158.1977.tb11312.x
Abstract
Sensitive and specific gas-liquid chromatographic methods were developed for the analysis of mexiletine and its metabolites in urine of man. The identity of the g.l.c. peaks was established by mass-spectrometry. The hydroxylamine (Va) was qualitatively identified and determined quantitatively after conversion to the more stable oxime (Vb). Selective extraction procedures, t.l.c. and derivatization with hexamethyldisilazane (HMDS) and trifluoroacetic anhydride (TFA) were used in the qualitative identification of the major metabolites (VI-IX), particularly in distinguishing the basic products VI and VII from their corresponding alcoholic products VIII and IX. The limit of detection of the g.l.c. method was 6 to 12 ng ml-1 for compounds I-IV, and 40 to 50 ng ml-1 for compounds Vb-IX.This publication has 9 references indexed in Scilit:
- COMPARISON OF PROCAINAMIDE AND MEXILETINE IN PREVENTION OF VENTRICULAR ARRHYTHMIAS AFTER ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1975
- THE RENAL EXCRETION OF MEXILETINE (Kö 1173) UNDER CONTROLLED CONDITIONS OF URINE pHPublished by Wiley ,1974
- Metabolism of amphetamines. Identification of N-oxygenated products by gas chromatography and mass spectrometryJournal of Pharmacy and Pharmacology, 1973
- MEXILETINE (KÖ1173) IN THE MANAGEMENT OF VENTRICULAR DYSRHYTHMIASThe Lancet, 1973
- TREATMENT OF VENTRICULAR ARRHYTHMIAS WITH MEXILETINE (K 1173)The Lancet, 1973
- Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urineJournal of Pharmacy and Pharmacology, 1973
- The identification, properties and analysis of N-hydroxyamphetamine—a metabolite of amphetamineJournal of Pharmacy and Pharmacology, 1973
- The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmiasBritish Journal of Pharmacology, 1972